Universal Quantum Partners with Open Quantum Institute to Tackle Endometriosis
Universal Quantum is partnering with the Open Quantum Institute to investigate the use of quantum computing in drug discovery for endometriosis, a condition affecting approximately 190 million people worldwide. The collaboration aims to develop non-hormonal therapeutics and aligns with OQI's commitment to the UN Sustainable Development Goals. While still in early stages, UQ anticipates that advancements in trapped-ion quantum computers will lead to significant breakthroughs in this area.
Theia Market Signal Identification - AI Assisted
Universal Quantum (UQ) is collaborating with the Open Quantum Institute (OQI) to explore quantum computing applications in drug discovery, focusing on endometriosis, a condition affecting about 190 million people globally. UQ, founded in 2018 and based in the UK, aims to develop non-hormonal therapeutics for underserved populations.
The project is part of OQI's mission to align quantum technologies with the UN Sustainable Development Goals. UQ plans to enhance quantum algorithms and engage with experts in biomedicine and computational chemistry. While the project is in early stages, UQ believes advancements in trapped-ion quantum computers will facilitate future breakthroughs.
Comments